Journal article · 2025 · Open access
Revolutionizing drug discovery from natural products: The roles of artificial intelligence and multi-omics in accelerating innovation
Acta Pharmaceutica Sinica B, 16(7), 4103–4127 · Published 23 December 2025 · DOI 10.1016/j.apsb.2025.12.030
In brief
“Revolutionizing drug discovery from natural products: The roles of artificial intelligence and multi-omics in accelerating innovation” is a 2025 journal article by Boyang Wang and 6 co-authors, published in Acta Pharmaceutica Sinica B. OpenAlex counts 28 citations as of 16 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Acta Pharmaceutica Sinica B.
- Citations
- 28
- Most cited in
- 2026 (28)
- Field-weighted impact
- 8.01
- References
- 260
- Authors
- 7
Abstract
Natural products and their derivatives have long been crucial in drug therapy, especially in traditional medicine. However, challenges in screening, isolation, characterization, and optimization have slowed their development in the pharmaceutical industry. Recent advancements in artificial intelligence (AI) and multi-omics technologies are revitalizing this field. AI offers powerful tools for understanding natural compounds, enhancing molecular representations, and supporting tasks such as binding prediction, drug repurposing, and retrosynthesis. Moreover, generative models are aiding in natural product optimization and the creation of pseudo-natural compounds. At the same time, multi-omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, have enabled high-throughput studies of plant traits, synthesis, regulatory mechanisms, and quality control, providing valuable data for AI model development. These advancements help accelerate the discovery of new compounds with medicinal potential. Furthermore, in the field of traditional Chinese medicine research, which is largely based on natural plant sources, AI systems exemplified by UNIQ system, combining AI and multi-omics, have been instrumental in mechanistic studies and new drug development. This study comprehensively discusses the algorithms and applications of AI and multi-omics technologies in the drug development of natural compounds and plants, as well as summarizing relevant databases which might provide high-quality data for the future development of AI algorithms targeting natural products.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Wang, B., Liu, Q., Zhao, W., Zhang, T., Zhang, D., Sutcharitchan, C., & Li, S. (2025). Revolutionizing drug discovery from natural products: The roles of artificial intelligence and multi-omics in accelerating innovation. Acta Pharmaceutica Sinica B, 16(7), 4103–4127. https://doi.org/10.1016/j.apsb.2025.12.030
MLA 9
Wang, Boyang, et al. “Revolutionizing drug discovery from natural products: The roles of artificial intelligence and multi-omics in accelerating innovation.” Acta Pharmaceutica Sinica B, vol. 16, no. 7, 2025, pp. 4103–4127. https://doi.org/10.1016/j.apsb.2025.12.030.
Chicago
Wang, Boyang, Qingyuan Liu, Weibo Zhao, Tingyu Zhang, Dingfan Zhang, Chayanis Sutcharitchan, and Shaobo Li. 2025. “Revolutionizing drug discovery from natural products: The roles of artificial intelligence and multi-omics in accelerating innovation.” Acta Pharmaceutica Sinica B 16 (7): 4103–4127. https://doi.org/10.1016/j.apsb.2025.12.030.
Harvard
Wang, B. et al. (2025) ‘Revolutionizing drug discovery from natural products: The roles of artificial intelligence and multi-omics in accelerating innovation’, Acta Pharmaceutica Sinica B, 16(7), pp. 4103–4127. doi:10.1016/j.apsb.2025.12.030.
IEEE
B. Wang et al., “Revolutionizing drug discovery from natural products: The roles of artificial intelligence and multi-omics in accelerating innovation,” Acta Pharmaceutica Sinica B, vol. 16, no. 7, pp. 4103–4127, 2025, doi: 10.1016/j.apsb.2025.12.030.
BibTeX
@article{wang2025revolutionizing,
title = {{Revolutionizing drug discovery from natural products: The roles of artificial intelligence and multi-omics in accelerating innovation}},
author = {Wang, Boyang and Liu, Qingyuan and Zhao, Weibo and Zhang, Tingyu and Zhang, Dingfan and Sutcharitchan, Chayanis and Li, Shaobo},
journal = {Acta Pharmaceutica Sinica B},
year = {2025},
volume = {16},
number = {7},
pages = {4103--4127},
doi = {10.1016/j.apsb.2025.12.030},
url = {https://doi.org/10.1016/j.apsb.2025.12.030}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- natural products
- drug discovery
- artificial intelligence
- multi-omics
- natural product derivatives
- drug repurposing
- retrosynthesis
- generative models
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Wang, B., Liu, Q., Zhao, W., Zhang, T., Zhang, D., Sutcharitchan, C., & Li, S. (2025). Revolutionizing drug discovery from natural products: The roles of artificial intelligence and multi-omics in accelerating innovation. Acta Pharmaceutica Sinica B, 16(7), 4103–4127. https://doi.org/10.1016/j.apsb.2025.12.030
How many times has this paper been cited?
28 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Acta Pharmaceutica Sinica B: sign in and open the full text from this page.
Who wrote this paper?
Boyang Wang, Qingyuan Liu, Weibo Zhao, Tingyu Zhang, Dingfan Zhang, Chayanis Sutcharitchan, Shaobo Li.
What is the DOI of this paper?
10.1016/j.apsb.2025.12.030, permanently at https://doi.org/10.1016/j.apsb.2025.12.030. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.